Title: Treating Picornavirus Infection by Targeting microRNA miR-141

Patent Number: 8,263,570

Filed: Dec. 15, 2009

Lead Inventor: Bing-Ching Ho, National Taiwan University

The invention, the patent's abstract states, involves treating “picornavirus infection by inhibiting miR-141 activity. Also disclosed herein are a method for [identifying] miR-141 inhibitory compounds and a method for identifying a target viral infection to be treated by anti-miR-141 therapy.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.